Bisoctrizole/Titanium dioxide

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameBisoctrizole/Titanium dioxide
Drug Alias NameRV3131A-MV1166V-0096-CR
ClassificationSmall molecules
Mechanisms of ActionPhotosensitizers
TargetsNot applicable
Therapy Area/IndicationsUrticaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsYes
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOrfagen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrfagen
Active IndicationsN/A
Inactive IndicationsUrticaria

Other Information

ATC CodeN/A
Related LinksN/A